Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Morning Alexa Flash Briefings of May 16th
Morning Alexa Flash Briefings
Cheddar Morning News Briefings of May 16th
Cheddar Morning News Briefings
NBC Pitches Ad Buyers Amid Writers' Strike
Cheddar News attended the upfront presentation by NBC Universal and broke down how this year's event was different from previous years due to the ongoing writers' strike.
Microsoft Bid to Buy Activision Blizzard Clears Key Hurdle but $69B Deal Still at Risk
The European Union has approved Microsoft’s $69 billion purchase of video game maker Activision Blizzard.
Analyst Breaks Downs Monday's Trading Session Ahead of Debt Ceiling Talks
Steve Sosnick, chief strategist with Interactive Brokers, joined Cheddar News to discuss Monday's light trading session ahead of debt ceiling discussions on Tuesday. Sosnick also weighed in on what the Federal Reserve could have in its sight.
General Motors Recalls 1 Million SUVs With Airbag Defect
General Motors (GM) has submitted a safety recall notification to the National Highway Traffic Safety Administration for 994,763 sports utility vehicles with defective airbag inflators.
Afternoon Alexa Flash Briefings of May15th
Afternoon Alexa Flash Briefings
Execs to Testify This Week on SVB and Signature Bank Collapses
Bankers are headed to Capitol Hill this week for multiple hearings probing into the failures of Silicon Valley Bank and Signature Bank in March.
Stock Market Today: Wall Street Rises Ahead of Updates on U.S. shoppers
Wall Street drifted higher ahead of reports that will show how much a slowing economy is hurting what’s prevented a recession so far: solid spending by U.S. households.
